Medicines for endometriosis and IVF, amongst other things, were deliberately deferred in defiance of the Pharmaceutical Benefits Advisory Committee. By contrast, because of the stable environment on our watch, in our time, we've been able to list over 2,200 new and amended medicines. That includes Ibrance, a medicine recently listed for metastatic or inoperable breast cancer. Three thousand women will save up to $55,000 a year and, above all else, have a real sense of hope and possibility for their future.